It was found that compared with the DCM group, silencing lncMEG3 significantly attenuated the mRNA levels of NLRP3, ASC, Caspase-1, IL-1β, and IL-18 in the hearts of diabetic mice (Figures 4G–K). This evidence concerns the gene IL1B and familial dilated cardiomyopathy.